405518-55-0

Basic information

• Product Name: 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid
• Synonyms: 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid;MPEG9-CH2COOH
• CAS NO: 405518-55-0
• Molecular Formula: C₂₁H₄₂O₁₂
• Molecular Weight: 486.55
• EINECS: -0
• Mol File: 405518-55-0.mol

Chemical Properties

• Boiling Point: 557.372 °C at 760 mmHg
• Flash Point: 175.904 °C
• Appearance: /
• Density: 1.122
• PKA: 3.39±0.10(Predicted)
• CAS DataBase Reference: 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid(405518-55-0)
• EPA Substance Registry System: 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid(405518-55-0)

Safety Data

• Hazardous Substances Data: 405518-55-0(Hazardous Substances Data)

Usage

Uses

Used in the Manufacturing of Waxes:
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid is used as a component in the production of waxes due to its long-chain structure and high melting point, providing stability and consistency to the final product.
Used in the Production of Lubricants:
As a component in lubricants, 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid offers excellent lubricating properties, reducing friction and wear in various mechanical applications.
Used in the Manufacturing of Plasticizers:
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid is used as a plasticizer, enhancing the flexibility and workability of various plastic materials.
Used in Pharmaceutical Industry:
3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid is used as an emulsifying agent in the production of pharmaceuticals, improving the stability and solubility of drug formulations.
Used in Cosmetics Industry:
In the cosmetics industry, 3,6,9,12,15,18,21,24,27,30-Decaoxahentriacontanoic acid is utilized for its moisturizing properties, providing hydration and improving the texture of cosmetic products.

Upstream product

• 6048-68-6 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-ol 

Relevant articles and documents

CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES

A novel cross-linked cytotoxic agents, pyrrolobenzo-diazepine dimer (PBD) derivatives, and their conjugates to a cell-binding molecule, a method for preparation of the conjugates and the therapeutic use of the conjugates.

A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS

The present invention relates to the conjugation of a tubulysin analog compound to a cell-binding molecule with branched/side-chain linkers for having better delivery of the conjugate compound and targeted treatment of abnormal cells. It also relates to a branched-linkage method of conjugation of a tubulysin analog molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and autoimmune disease.

CONJUGATION LINKERS CONTAINING 2,3-DIAMINOSUCCINYL GROUP

Provided is a conjugate of a cytotoxic drug/molecule to a cell-binding molecule with a bis-linker (adual-linker) containing a 2, 3-diaminosuccinyl group. It also relates to preparation of the conjugate of a cytotoxic drug/molecule to a cell-binding molecule with the bis-linker, particularly when the drug having functional groups of amino, hydroxyl, diamino, amino-hydroxyl, dihydroxyl, carboxyl, hydrazine, aldehyde and thiol for conjugation with the bis-linker in a specific manner, as well as the therapeutic use of the conjugates.

A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS

The present invention relates to the conjugation of a tubulysin analog compound to a cell-binding molecule with branched/side-chain linkers for having better delivery of the conjugate compound and targeted treatment of abnormal cells. It also relates to a branched-linkage method of conjugation of a tubulysin analog molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and autoimmune disease.

Novel alkanoic acid derivaties

There are provided according to the invention compounds of the formula (I) or a salt or solvate thereof, wherein: n represents an integer 1 to 6; N represents an integer 1 to 15; R1 represents (CO)xC1-9alkyl or (CO)xC1-9fluoroalkyl, which fluoroalkyl moiety contains at least 1 fluorine atom and not more than 3 consecutive perfluorocarbon atoms wherein x represents 0 or 1; and R2 and R3 independently represent C1-3alkyl or hydrogen. There are also provided pharmaceutical aerosol formulations employing said compounds as suspension stabilising agents.